Kresge Hearing Research Institute, Department of Otolaryngology, University of Michigan, 1150 West Medical Center Dr., Ann Arbor, MI 48109-5648, USA.
Hear Res. 2013 Mar;297:99-105. doi: 10.1016/j.heares.2012.11.017. Epub 2012 Dec 21.
Animal studies on inner ear development, repair and regeneration provide understanding of molecular pathways that can be harnessed for treating inner ear disease. Use of transgenic mouse technology, in particular, has contributed knowledge of genes that regulate development of hair cells and innervation, and of molecular players that can induce regeneration, but this technology is not applicable for human treatment, for practical and ethical reasons. Therefore other means for influencing gene expression in the inner ear are needed. We describe several gene vectors useful for inner ear gene therapy and the practical aspects of introducing these vectors into the ear. We then review the progress toward using gene transfer for therapies in both auditory and balance systems, and discuss the technological milestones needed to advance to clinical application of these methods.
动物内耳发育、修复和再生的研究为治疗内耳疾病提供了对可利用的分子途径的理解。转基因小鼠技术的应用,特别是,为调节毛细胞和神经支配发育的基因以及可以诱导再生的分子参与者的知识做出了贡献,但由于实际和伦理原因,该技术不适用于人类治疗。因此,需要其他方法来影响内耳中的基因表达。我们描述了几种用于内耳基因治疗的基因载体,以及将这些载体引入耳朵的实际方面。然后,我们回顾了使用基因转移治疗听觉和平衡系统疾病的进展,并讨论了将这些方法推进到临床应用所需的技术里程碑。